Equities
  • Price (EUR)0.3666
  • Today's Change0.000 / 0.11%
  • Shares traded700.00
  • 1 Year change-47.11%
  • Beta--
Data delayed at least 15 minutes, as of Mar 28 2024 07:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alibaba Health Information Technology Ltd is an investment holding company mainly engaged in the provision of Internet solutions for the medical and pharmaceutical industry, and is Alibaba Group’s healthcare flagship platform. The Company is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data.

  • Revenue in HKD (TTM)30.59bn
  • Net income in HKD887.38m
  • Incorporated1998
  • Employees1.55k
  • Location
    Alibaba Health Information Technology LtdSuites 7001-7005, 70/FTwo International Finance Cent8 Finance Street, Central Hong KongHKG
  • Phone+852 25839333
  • Fax+852 22155200
  • Websitehttps://www.alihealth.cn/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
241:HKG since
announced
Transaction
value
AJK Technology Holding LtdAnnounced28 Nov 202328 Nov 2023Announced-31.61%1.78bn
Data delayed at least 15 minutes, as of Mar 28 2024 08:08 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.